Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Rapid Vessel Occlusion (Rapid VO)

K-Number: K261085 · 2026-07-13

ApplicantiSchemaview
Decision Date2026-07-13
Product CodeQAS
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Rapid Vessel Occlusion (Rapid VO) is the device name listed in this FDA 510(k) record. The listed applicant is iSchemaview. It received FDA 510(k) clearance on 2026-07-13 under 510(k) number K261085. The device is classified under product code QAS. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Rapid Vessel Occlusion (Rapid VO)?

Rapid Vessel Occlusion (Rapid VO) is a medical device that received FDA 510(k) clearance on 2026-07-13. The listed applicant is iSchemaview. The 510(k) number is K261085.

When did Rapid Vessel Occlusion (Rapid VO) receive FDA 510(k) clearance?

Rapid Vessel Occlusion (Rapid VO) received FDA 510(k) clearance on 2026-07-13, under 510(k) number K261085.

Who is the listed applicant for Rapid Vessel Occlusion (Rapid VO)?

The FDA 510(k) record lists iSchemaview as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Rapid Vessel Occlusion (Rapid VO)?

The FDA product code for Rapid Vessel Occlusion (Rapid VO) is QAS.

Other records listing iSchemaview as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 23 devices →

Related Devices (Code: QAS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.